Patent details
LUC00311 Product Name: Etranacogène dezaparvovec (vecteur viral adéno-associé contenant un dérivé de Padoue optimisé au niveau du codon du gène du facteur IX de coagulation humain pour le traitement de l'hémophilie B)
Basic Information
- Publication number:
- LUC00311
- Type:
- SPC
- SPC Type:
- Medical
- Basic Patent Number:
- EP191745173
- Legal Status:
- Inactive
- Application number:
- LUC00311
- First applicant's nationality:
- Procedural language:
- French
Marketing Authorization
- Marketing Authorization Number:
- EU/1/22/1715
- Marketing Authorization Type:
- Marketing Authorization Date:
- 23/02/2023
- Marketing Authorization Status:
- Accepted
- Marketing Authorization Country:
- Luxembourg (LU)
Dates
- Filing date:
- 25/07/2023
- First Marketing Authorization date:
- 23/02/2023
- Grant date:
- 02/02/2026
- Activation date:
- Publication date:
- 26/07/2023
- Lapsed date:
- Expiration date:
- Renunciation date:
- Revocation date:
- Annulment date:
- Basic SPC Expiration:
- 15/09/2034
- SPC Extension Expiration:
- 15/09/2034
- Rejection date:
- Withdrawal date:
Owner
- From:
- 25/07/2023
- Name:
- uniQure biopharma B.V.
- Address:
- Paasheuvelweg 25a, 1105 BP Amsterdam, Netherlands (NL)
Agent
1
- Name:
- Dennemeyer & Associates S.A.
- From:
- 21/01/2025
- Address:
- 55, rue des Bruyères, L-1274, HOWALD, Luxembourg (LU)
- To:
2
- Name:
- OFFICE FREYLINGER S.A.
- From:
- 25/07/2023
- Address:
- Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
- To:
- 21/01/2025
Publication
Bulletin
1
- Bulletin Heading:
- SPC1
- Bulletin edition number:
- 2023/09
- Publication date:
- 01/08/2023
- Description:
- Section C : Published requests for Supplementary Protection Certificates – I1 publication
2
- Bulletin Heading:
- SPC2
- Bulletin edition number:
- 2026/04
- Publication date:
- 03/03/2026
- Description:
- Section D : Granted supplementary protection certificates – I2 publication
Other
- Note:
- Suspension de la procédure de délivrance sur requête du déposant / Suspension of the grant procedure at the request of the applicant (12/03/2024)
Annual Fees
- Annual Fee Due Date:
- 01/10/2029
- Annual Fee Number:
- 21
- Annual Fee Amount:
- 410 Euro
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|---|---|
| 30/07/2025 | General Document | 1 |
| 31/07/2025 | Outgoing Correspondence | 1 |
| 21/01/2025 | Request For Change | 1 |
| 22/01/2025 | Outgoing Correspondence | 1 |
| 21/01/2025 | General Document | 1 |
| 28/02/2025 | Incoming Correspondence (Email) | 2 |
| 28/02/2025 | Outgoing Correspondence | 2 |
| 28/02/2025 | General Document | 1 |
| 28/02/2025 | General Document | 4 |
| 12/03/2024 | Outgoing Correspondence | 1 |
| 12/03/2024 | Incoming Correspondence (Post) | 1 |
| 25/07/2023 | Application Form | 3 |
| 25/07/2023 | Marketing authorization | 4 |
| 25/07/2023 | Summary of the product caracteristics | 48 |
| 25/07/2023 | MA publication | 8 |
| 26/07/2023 | Outgoing Correspondence | 1 |
| 28/11/2025 | General Document | 1 |
| 28/11/2025 | Outgoing Correspondence | 2 |
| 28/11/2025 | General Document | 1 |
| 28/11/2025 | Incoming Correspondence (Email) | 2 |
| 26/07/2023 | Publication | 1 |
| 02/02/2026 | Publication | 1 |
| 02/02/2026 | Certificate | 1 |
| 02/02/2026 | Outgoing Correspondence | 1 |